VALNEVA USA, INC.

Lobbying for VALNEVA USA, INC. · Vaccine company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$110,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Maryland

Official filing document

Government bodies contacted 3

Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the State Stockpile Grant program; Issues related to Strategic National Stockpile procurement regarding new emerging infection diseases and in relation to the Preparedness Act (PAHPA) reauthorization; Issues related to the FDA's Priority Review Voucher; Issues related to reauthorization of the publican health emergency medical countermeasures enterprise; Enhancing immunization access for military dependents

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.